Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

The evolving NHS: How can Pharma and Medtech support the NHS in 2022?  - NHS Insights Panel Discussion

The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion

FromPharma Market Access Insights - from Mtech Access


The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion

FromPharma Market Access Insights - from Mtech Access

ratings:
Length:
63 minutes
Released:
Jan 17, 2022
Format:
Podcast episode

Description

Pharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical challenges the NHS has faced in 2021 and how Pharma and Medtech can best support the NHS in 2022.We were joined by some of Mtech Access’s closest and most insightful friends:- David Thorne (Director, Mtech Access and Well Up North PCN) our Policy expert- Patrick McGinley (Head of Costing and Service Line Reporting, Maidstone and Tunbridge Wells NHS Trust) our Hospitals and Finance expert- Liz Cross (Advanced Nurse Practitioner, Attenborough Surgery, Watford) our Primary Care and Clinical expert- Ewan Maule (Interim Chief Pharmacist, North East and North Cumbria ICS) our System and Medicines expertThis podcast was originally broadcast as a live webinar on 10th December 2021.Learn more at https://mtechaccess.co.uk/evolving-nhs-pharma-medtech-support-2022/
Released:
Jan 17, 2022
Format:
Podcast episode

Titles in the series (56)

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Mtech Access. Our first series focuses on the NHS response to the COVID-19 pandemic.